found that the deletion of NLRP3 inflammasome is closely related to the development of hepatocellular carcinoma, while 17β-estradiol inhibits hepatocellular carcinoma via activating NLRP3 (5, 6). Here, NLRP3 is linked to hepatocellular carcinoma.